Walz Andrew Benjamin 4
4 · CHEVRON CORP · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Chevron (CVX) President Andrew Walz Sells 22,200 Shares
What Happened Andrew Walz, President, Downstream & Chemicals at Chevron (CVX), exercised stock options to acquire a total of 22,200 shares on Feb 3, 2026 and sold those 22,200 shares in the open market the same day. The option exercises required aggregate cash payments of $2,600,751 (4,100 @ $117.24; 6,900 @ $125.35; 7,200 @ $113.01; 4,000 @ $110.37). The subsequent weighted-average sale of 22,200 shares was at $176.53, grossing $3,919,050. Net proceeds before taxes/fees were roughly $1.32 million.
Key Details
- Transaction date: Feb 3, 2026; Form 4 filed Feb 5, 2026 (timely).
- Exercises (M): 4,100; 6,900; 7,200; 4,000 shares at exercise prices $117.24, $125.35, $113.01, $110.37 respectively (total cash paid $2,600,751).
- Sale (S): 22,200 shares sold at a weighted-average price of $176.53 for $3,919,050. (Executed in multiple trades priced between $176.44 and $176.65 per footnote.)
- Derivative reporting: the filing also shows corresponding $0.00 disposition lines reflecting conversion/exercise of the options into shares.
- Shares owned after the transaction: not specified in the provided filing text.
- Notable footnotes: F1 notes a 1-share adjustment from a previously reported RSU settlement; F2 clarifies the sale price range and availability of trade-level detail; F3–F6 identify option grants (1/25/2017, 1/31/2018, 1/30/2019, 1/29/2020) and their vesting schedules.
Context These entries reflect an option exercise followed by an immediate or same-day open-market sale of the resulting shares (common "exercise-and-sell" pattern). The $0.00 derivative disposition lines simply document conversion of options into shares. The filing is informational and does not indicate the insider's future expectations for the stock; purchases are typically considered more indicative of bullish sentiment than routine sales following exercises.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-03$117.24/sh+4,100$480,684→ 4,766 total - Exercise/Conversion
Common Stock
2026-02-03$125.35/sh+6,900$864,915→ 11,666 total - Exercise/Conversion
Common Stock
2026-02-03$113.01/sh+7,200$813,672→ 18,866 total - Exercise/Conversion
Common Stock
2026-02-03$110.37/sh+4,000$441,480→ 22,866 total - Sale
Common Stock
[F2]2026-02-03$176.53/sh−22,200$3,919,050→ 666 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F3]2026-02-03−4,100→ 0 totalExercise: $117.24Exp: 2027-01-25→ Common Stock (4,100 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F4]2026-02-03−6,900→ 0 totalExercise: $125.35Exp: 2028-01-31→ Common Stock (6,900 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F5]2026-02-03−7,200→ 0 totalExercise: $113.01Exp: 2029-01-30→ Common Stock (7,200 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
[F6]2026-02-03−4,000→ 6,600 totalExercise: $110.37Exp: 2030-01-29→ Common Stock (4,000 underlying)
- 8,799(indirect: By 401(k))
Common Stock
Footnotes (6)
- [F1]This number is adjusted to include previously rounded fractional amounts (1 share) in connection with the settlement of the restricted stock unit award previously reported by the reporting person though no acquisition occurred.
- [F2]This transaction was executed in multiple trades priced between $176.44 and $176.65. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
- [F3]Option granted 1/25/2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively.
- [F4]Option granted 1/31/2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively.
- [F5]Option granted 1/30/2019. One-third of the shares subject to the option vested on January 31, 2020, January 31, 2021 and January 31, 2022, respectively.
- [F6]Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.